Pembroke Management, LTD Charles River Laboratories International, Inc. Transaction History

Pembroke Management, LTD

$769 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$255.51 - $362.11 $9.1 Million - $12.9 Million	-35,633 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$351.38 - $448.68 $12.1 Million - $15.4 Million	-34,381 Reduced 49.11%	35,633 $13.4 Million
Q3 2021 Nov 08, 2021	BUY	$372.64 - $458.3 $95,023 - $116,866	255 Added 0.37%	70,014 $28.9 Million
Q2 2021 Aug 11, 2021	SELL	$294.17 - $371.65 $4.21 Million - $5.32 Million	-14,302 Reduced 17.01%	69,759 $25.8 Million
Q1 2021 May 06, 2021	SELL	$249.67 - $299.48 $8.01 Million - $9.61 Million	-32,076 Reduced 27.62%	84,061 $24.4 Million
Q4 2020 Feb 05, 2021	SELL	$222.0 - $252.62 $2.04 Million - $2.32 Million	-9,202 Reduced 7.34%	116,137 $29 Million
Q3 2020 Nov 04, 2020	BUY	$175.56 - $226.45 $1,580 - $2,038	9 Added 0.01%	125,339 $28.4 Million
Q2 2020 Aug 03, 2020	SELL	$118.84 - $189.72 $862,540 - $1.38 Million	-7,258 Reduced 5.47%	125,330 $21.9 Million
Q1 2020 Apr 28, 2020	BUY	$98.9 - $178.34 $1.43 Million - $2.58 Million	14,491 Added 12.27%	132,588 $16.7 Million
Q4 2019 Jan 29, 2020	SELL	$126.05 - $152.76 $2.14 Million - $2.59 Million	-16,943 Reduced 12.55%	118,097 $18 Million
Q3 2019 Oct 29, 2019	BUY	$125.07 - $143.67 $3.96 Million - $4.55 Million	31,689 Added 30.66%	135,040 $17.9 Million
Q2 2019 Jul 24, 2019	SELL	$123.4 - $148.55 $109,085 - $131,318	-884 Reduced 0.85%	103,351 $14.7 Million
Q1 2019 Apr 12, 2019	BUY	$104.82 - $146.73 $3.66 Million - $5.12 Million	34,900 Added 50.34%	104,235 $15.1 Million
Q4 2018 Jan 25, 2019	SELL	$105.09 - $137.23 $1.94 Million - $2.53 Million	-18,450 Reduced 21.02%	69,335 $7.85 Million
Q3 2018 Oct 29, 2018	SELL	$112.11 - $134.54 $3.6 Million - $4.32 Million	-32,100 Reduced 26.78%	87,785 $11.8 Million
Q2 2018 Jul 27, 2018	SELL	$102.37 - $117.25 $389,006 - $445,550	-3,800 Reduced 3.07%	119,885 $13.5 Million
Q1 2018 Apr 23, 2018	BUY	$98.19 - $115.2 $4.53 Million - $5.32 Million	46,150 Added 59.52%	123,685 $13.2 Million
Q4 2017 Jan 31, 2018	SELL	$100.43 - $118.09 $5.02 Million - $5.9 Million	-50,000 Reduced 39.2%	77,535 $8.49 Million
Q3 2017 Nov 08, 2017	BUY	$96.72 - $109.26 $12.3 Million - $13.9 Million	127,535	127,535 $13.8 Million

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.23 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$1.02 Billion
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$753 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$429 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$390 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pembroke Management, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pembroke Management, LTD with notifications on news.

Account